These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25851895)

  • 1. Granulocyte colony-stimulating factor for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled study of Iranian patients.
    Amirzagar N; Nafissi S; Tafakhori A; Modabbernia A; Amirzargar A; Ghaffarpour M; Siroos B; Harirchian MH
    J Clin Neurol; 2015 Apr; 11(2):164-71. PubMed ID: 25851895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human granulocyte-colony stimulating factor administration for treating amyotrophic lateral sclerosis: A pilot study.
    Nefussy B; Artamonov I; Deutsch V; Naparstek E; Nagler A; Drory VE
    Amyotroph Lateral Scler; 2010; 11(1-2):187-93. PubMed ID: 19449238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial).
    Salamone P; Fuda G; Casale F; Marrali G; Lunetta C; Caponnetto C; Mazzini L; La Bella V; Mandrioli J; Simone IL; Moglia C; Calvo A; Tarella C; Chio A;
    BMJ Open; 2020 Mar; 10(3):e034049. PubMed ID: 32209625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G-CSF prevents the progression of structural disintegration of white matter tracts in amyotrophic lateral sclerosis: a pilot trial.
    Duning T; Schiffbauer H; Warnecke T; Mohammadi S; Floel A; Kolpatzik K; Kugel H; Schneider A; Knecht S; Deppe M; Schäbitz WR
    PLoS One; 2011 Mar; 6(3):e17770. PubMed ID: 21423758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary investigation of effect of granulocyte colony stimulating factor on amyotrophic lateral sclerosis.
    Zhang Y; Wang L; Fu Y; Song H; Zhao H; Deng M; Zhang J; Fan D
    Amyotroph Lateral Scler; 2009; 10(5-6):430-1. PubMed ID: 19922135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte-colony stimulating factor administration for neurological improvement in patients with postrehabilitation chronic incomplete traumatic spinal cord injuries: a double-blind randomized controlled clinical trial.
    Derakhshanrad N; Saberi H; Yekaninejad MS; Joghataei MT; Sheikhrezaei A
    J Neurosurg Spine; 2018 Jul; 29(1):97-107. PubMed ID: 29701561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis.
    Tanaka M; Kikuchi H; Ishizu T; Minohara M; Osoegawa M; Motomura K; Tateishi T; Ohyagi Y; Kira J
    J Neuropathol Exp Neurol; 2006 Aug; 65(8):816-25. PubMed ID: 16896315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of continuous high-dose G-CSF administration on hematopoietic stem cell mobilization and telomere length in patients with amyotrophic lateral sclerosis - a pilot study.
    Iberl S; Meyer AL; Müller G; Peters S; Johannesen S; Kobor I; Beier F; Brümmendorf TH; Hart C; Schelker R; Herr W; Bogdahn U; Grassinger J
    Cytokine; 2019 Aug; 120():192-201. PubMed ID: 31100684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter study.
    Chiò A; Mora G; La Bella V; Caponnetto C; Mancardi G; Sabatelli M; Siciliano G; Silani V; Corbo M; Moglia C; Calvo A; Mutani R; Rutella S; Gualandi F; Melazzini M; Scimè R; Petrini M; Bondesan P; Garbelli S; Mantovani S; Bendotti C; Tarella C;
    Muscle Nerve; 2011 Feb; 43(2):189-95. PubMed ID: 21254083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploratory double-blind, parallel-group, placebo-controlled study of edaravone (MCI-186) in amyotrophic lateral sclerosis (Japan ALS severity classification: Grade 3, requiring assistance for eating, excretion or ambulation).
    WRITING GROUP ON BEHALF OF THE EDARAVONE (MCI-186) ALS 18 STUDY GROUP
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Oct; 18(sup1):40-48. PubMed ID: 28872915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte-colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trial.
    Tarella C; Rutella S; Gualandi F; Melazzini M; Scimè R; Petrini M; Moglia C; Ulla M; Omedé P; Bella VL; Corbo M; Silani V; Siciliano G; Mora G; Caponnetto C; Sabatelli M; Chiò A;
    Cytotherapy; 2010; 12(1):50-9. PubMed ID: 19878077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study.
    de la Rubia JE; Drehmer E; Platero JL; Benlloch M; Caplliure-Llopis J; Villaron-Casales C; de Bernardo N; AlarcÓn J; Fuente C; Carrera S; Sancho D; GarcÍa-Pardo P; Pascual R; JuÁrez M; Cuerda-Ballester M; Forner A; Sancho-Castillo S; Barrios C; Obrador E; Marchio P; Salvador R; Holmes HE; Dellinger RW; Guarente L; Estrela JM
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Feb; 20(1-2):115-122. PubMed ID: 30668199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NurOwn, phase 2, randomized, clinical trial in patients with ALS: Safety, clinical, and biomarker results.
    Berry JD; Cudkowicz ME; Windebank AJ; Staff NP; Owegi M; Nicholson K; McKenna-Yasek D; Levy YS; Abramov N; Kaspi H; Mehra M; Aricha R; Gothelf Y; Brown RH
    Neurology; 2019 Dec; 93(24):e2294-e2305. PubMed ID: 31740545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creatine for amyotrophic lateral sclerosis/motor neuron disease.
    Pastula DM; Moore DH; Bedlack RS
    Cochrane Database Syst Rev; 2010 Jun; (6):CD005225. PubMed ID: 20556761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis.
    Elia AE; Lalli S; Monsurrò MR; Sagnelli A; Taiello AC; Reggiori B; La Bella V; Tedeschi G; Albanese A
    Eur J Neurol; 2016 Jan; 23(1):45-52. PubMed ID: 25664595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of fluid-attenuated inversion recovery MRI data analyzed by the lesion segmentation toolbox in amyotrophic lateral sclerosis.
    Wirth AM; Johannesen S; Khomenko A; Baldaranov D; Bruun TH; Wendl C; Schuierer G; Greenlee MW; Bogdahn U
    J Magn Reson Imaging; 2019 Aug; 50(2):552-559. PubMed ID: 30569457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Open-Label, Prospective Study Evaluating the Clinical and Immunological Effects of Higher Dose Granulocyte Colony-Stimulating Factor in ALS.
    Pocock K; Suresh N; Suradi Y; Dang S; Harvey B; Cao C; Sutherland K; Lin X; Vu TH; Gooch C
    J Clin Neuromuscul Dis; 2020 Mar; 21(3):127-134. PubMed ID: 32073458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker Supervised G-CSF (Filgrastim) Response in ALS Patients.
    Johannesen S; Budeus B; Peters S; Iberl S; Meyer AL; Kammermaier T; Wirkert E; Bruun TH; Samara VC; Schulte-Mattler W; Herr W; Schneider A; Grassinger J; Bogdahn U
    Front Neurol; 2018; 9():971. PubMed ID: 30534107
    [No Abstract]   [Full Text] [Related]  

  • 19. ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral Sclerosis.
    Lingor P; Weber M; Camu W; Friede T; Hilgers R; Leha A; Neuwirth C; Günther R; Benatar M; Kuzma-Kozakiewicz M; Bidner H; Blankenstein C; Frontini R; Ludolph A; Koch JC;
    Front Neurol; 2019; 10():293. PubMed ID: 30972018
    [No Abstract]   [Full Text] [Related]  

  • 20. Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial.
    Cudkowicz ME; van den Berg LH; Shefner JM; Mitsumoto H; Mora JS; Ludolph A; Hardiman O; Bozik ME; Ingersoll EW; Archibald D; Meyers AL; Dong Y; Farwell WR; Kerr DA;
    Lancet Neurol; 2013 Nov; 12(11):1059-67. PubMed ID: 24067398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.